GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.75 $4.97 Thursday, 18th Apr 2024 ALDX stock ended at $3.98. This is 0.252% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 4.63% from a day low at $3.89 to a day high of $4.07.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2021-07-07 $10.72 $10.75 $10.11 $10.39 747 143
2021-07-06 $11.17 $11.24 $10.63 $10.77 928 950
2021-07-02 $11.31 $11.33 $10.69 $10.92 690 567
2021-07-01 $11.43 $11.45 $11.11 $11.31 758 636
2021-06-30 $11.47 $11.53 $11.17 $11.33 497 629
2021-06-29 $11.98 $12.01 $11.37 $11.41 532 325
2021-06-28 $11.55 $11.97 $11.53 $11.92 654 441
2021-06-25 $11.32 $11.71 $11.29 $11.47 6 820 977
2021-06-24 $11.25 $11.35 $11.13 $11.25 995 176
2021-06-23 $11.34 $11.50 $11.18 $11.23 1 386 554
2021-06-22 $12.12 $12.12 $11.24 $11.31 945 296
2021-06-21 $12.10 $12.20 $11.80 $11.92 806 235
2021-06-18 $11.93 $12.23 $11.76 $11.92 1 429 926
2021-06-17 $11.89 $12.29 $11.87 $12.15 424 626
2021-06-16 $11.96 $12.11 $11.52 $11.95 608 294
2021-06-15 $12.30 $12.38 $11.92 $12.04 603 927
2021-06-14 $12.44 $12.54 $12.16 $12.29 883 129
2021-06-11 $12.53 $12.73 $12.27 $12.34 324 252
2021-06-10 $12.58 $12.78 $12.30 $12.41 492 045
2021-06-09 $13.13 $13.18 $12.42 $12.57 1 230 848
2021-06-08 $13.00 $13.06 $12.66 $12.97 734 774
2021-06-07 $12.72 $13.18 $12.63 $12.91 1 084 121
2021-06-04 $12.59 $12.89 $12.49 $12.64 476 756
2021-06-03 $12.50 $12.66 $12.33 $12.49 386 542
2021-06-02 $12.25 $12.54 $12.15 $12.54 640 194
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT